Search Within

Mark Kris

  1. "Computational and Structural Biology Program Faculty"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  2. Computational and Structural Biology Program Faculty (9)
  3. Department of Medicine (9)
  4. Sloan Kettering Institute Faculty (9)
  5. Solid Tumor Oncology Division (9)
  6. Thoracic Oncology (9)

More Groups

People
  1. Colin Begg (5)
  2. Bernard Park (4)
  3. Dana Pe'er (4)
  4. Gregory Riely (4)
  5. Helena Yu (4)
  6. Hira Rizvi (4)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2008 (2)
  4. 2005 (2)
  5. 2003 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal of Thoracic Oncology (2)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Lung Cancer (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Elsevier Ireland Ltd. (1)
  5. Oxford University Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer
    Journal Article

    Schoenfeld, A. J.; Chan, J. M.; Kubota, D.; Sato, H.; Rizvi, H.; Daneshbod, Y.; Chang, J. C.; Paik, P. K.; Offin, M.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Evaluation of DNA damage, repair, and exposures in patients with lung cancer
    Meeting Abstract

    Mujumdar, U.; Park, B. J.; Begg, C. B.; Patel, H.; Siu-Lau, P.K.; Rusch, V. W.; Kris, M. G.; Orlow, I.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • DNA damage and repair capacity in patients with lung cancer: Prediction of multiple primary tumors
    Journal Article

    Orlow, I.; Park, B. J.; Mujumdar, U.; Patel, H.; Siu-Lau, P.; Clas, B. A.; Downey, R.; Flores, R.; Bains, M.; Rizk, N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Constitutive genetic instability in patients with multiple, primary non-small cell lung cancers
    Meeting Abstract

    Park, B. J.; Orlow, I.; Mujumdar, U.; Ginex, P. K.; Clas, B. A.; Kris, M. G.; Rusch, V. W.; Begg, C. B.; Berwick, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Genetic instability, response to DNA damage, and repair capacity in individuals with multiple primary non-small cell lung cancers
    Meeting Abstract

    Orlow, I.; Park, B.; Clas, B.; Mujumdar, U.; Dominguez, G.; Bhingradia, H.; Ginex, P.; Kris, M.; Rusch, V.; Begg, C.; more...
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Variations in lung cancer risk among smokers
    Journal Article

    Bach, P. B.; Kattan, M. W.; Thornquist, M. D.; Kris, M. G.; Tate, R. C.; Barnett, M. J.; Hsieh, L.; Begg, C. B.
    JNCI: Journal of the National Cancer Institute (2003)

    Fulltext@MSK | Save